Sapropterin and Levodopa: Interaction Details

Brand names
Levodopa
Inbrija
Sapropterin
KuvanJavygtorZelvysia
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Levodopa

Brand name
  • Inbrija

We don't have a drug information page for Levodopa yet. Have a question about Levodopa? Ask a pharmacist, free →

Sapropterin

Brand names
  • Kuvan
  • Javygtor
  • Zelvysia

What Happens When You Take Sapropterin With Levodopa

What can happen when they are taken together (rated Major)

Increased risk of neurologic disorders

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When levodopa is given together with sapropterin, patients who already have an underlying neurologic disorder have experienced neurologic events, including convulsions, over-stimulation, and irritability. Any change in neurologic status should be watched for during of the two drugs.1

The Sapropterin and Levodopa Interaction, Explained

Levodopa (used for Parkinson's disease) and sapropterin (used for PKU, a condition affecting how the body handles phenylalanine) can sometimes affect the brain and nerves when taken together. Reports describe seizures, feeling overly wound up or stimulated, and irritability, mostly in people who already have a neurologic condition. The likely reason is that sapropterin may raise the amount of tyrosine the body has available, which can change brain chemistry.

This does not mean everyone who takes both will have a problem. Keep taking your medicines as prescribed, and tell your pharmacist or doctor about any new twitching, agitation, mood changes, or seizures. Your care team can watch for these changes and manage this safely.

Interaction: Levodopa with sapropterin may increase the risk of neurologic adverse effects (convulsions, over-stimulation, irritability), reported in patients with underlying neurologic disorders.

  • Proposed mechanism: increased tyrosine availability (sapropterin is a phenylalanine hydroxylase cofactor), with potential downstream effects on catecholaminergic activity alongside levodopa. Not a -mediated PK interaction.
  • Onset: unspecified. Evidence: probable. Severity on file: major.
  • Management: monitor for changes in neurologic status during , especially in patients with pre-existing neurologic disease. Report seizures, agitation, or irritability promptly and reassess therapy as clinically indicated.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Sapropterin and Levodopa Interact

The likely mechanism

Increased tyrosine availability

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Sapropterin and Levodopa Interaction

Your care team can manage this combination mainly through monitoring. They may watch more closely for changes in how your nervous system is working, especially if you already have a neurologic condition.

  • Keep taking both medicines exactly as prescribed.
  • Tell your pharmacist or prescriber that you use both levodopa and sapropterin.
  • Report new seizures, unusual agitation or restlessness, irritability, or other changes in your nervous system right away.
  • Do not change or stop either medicine on your own. Your team will decide whether any adjustment is needed.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Sapropterin or Levodopa need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: KUVAN oral tablets, oral powder for solution, sapropterin dihydrochloride oral tablets, oral powder for solution

    In a 10-year postmarketing surveillance program for a different formulation of sapropterin that was used for an indication other than phenylketonuria, three patients with underlying neurologic disorders experienced convulsions, worsening of convulsions, over-stimulation, or irritability during of levodopa and sapropterin.1

Sapropterin and Levodopa: Common Questions

How serious is the Sapropterin and Levodopa interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Sapropterin and Levodopa interaction managed?

Your care team can manage this combination mainly through monitoring. They may watch more closely for changes in how your nervous system is working, especially if you already have a neurologic condition. Keep taking both medicines exactly as prescribed. Tell your pharmacist or prescriber that you use both levodopa and sapropterin. Report new seizures, unusual agitation or restlessness, irritabilit… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Sapropterin and Levodopa Interaction

Ask in your own words about taking Sapropterin and Levodopa together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: KUVAN(R) oral tablets, oral powder for solution, sapropterin dihydrochloride oral tablets, oral powder for solution. BioMarin Pharmaceutical Inc (per FDA), Novato, CA, 2019. DailyMed
Was this write-up helpful?

Other Serious Interactions of Sapropterin and Levodopa

Also serious with Levodopa

Also serious with Sapropterin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Levodopa

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.